{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T15:42:50Z","timestamp":1782229370257,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2003,10,1]],"date-time":"2003-10-01T00:00:00Z","timestamp":1064966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,4]],"date-time":"2015-12-04T00:00:00Z","timestamp":1449187200000},"content-version":"vor","delay-in-days":4447,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology Symposium Proceedings"],"published-print":{"date-parts":[[2003,10]]},"DOI":"10.1046\/j.1087-0024.2003.00811.x","type":"journal-article","created":{"date-parts":[[2003,9,22]],"date-time":"2003-09-22T16:49:39Z","timestamp":1064249379000},"page":"207-211","source":"Crossref","is-referenced-by-count":41,"title":["Therapy of Alopecia Areata: On the Cusp and in the Future"],"prefix":"10.1016","volume":"8","author":[{"given":"Vera H.","family":"Price","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1046\/j.1087-0024.2003.00811.x_bb0010","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1172\/JCI5857","article-title":"CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris","volume":"103","author":"Abrams","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1087-0024.2003.00811.x_bb0015","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/archderm.135.2.187","article-title":"Interleukin 10 treatment of psoriasis: Clinical results of a phase II trial","volume":"135","author":"Asadullah","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1046\/j.1087-0024.2003.00811.x_bb0020","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1046\/j.1523-1747.2000.00828.x","article-title":"Role of cytotoxic T cells in chronic alopecia areata","volume":"114","author":"Bodemer","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1087-0024.2003.00811.x_bb0025","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1046\/j.1523-1747.2002.01811.x","article-title":"Gene array profiling and immunomodulation studies define a cell-mediated immune response underlying the pathogenesis of alopecia areata in a mouse model and humans","volume":"119","author":"Carroll","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1087-0024.2003.00811.x_bb0030","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/S0140-6736(00)04954-0","article-title":"Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: A randomised trial","volume":"357","author":"Chaudhari","year":"2001","journal-title":"Lancet"},{"key":"10.1046\/j.1087-0024.2003.00811.x_bb0035","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/sj.jidsp.5640214","article-title":"The genetic basis of alopecia areata: HLA associations with patchy alopecia areata versus alopecia totalis and alopecia universalis","volume":"4","author":"Colombe","year":"1999","journal-title":"J Invest Dermatol Symp Proc The"},{"key":"10.1046\/j.1087-0024.2003.00811.x_bb0040","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1067\/mjd.2002.122187","article-title":"Safety and efficacy of pimecro-limus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents","volume":"46","author":"Eichenfield","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.1087-0024.2003.00811.x_bb0045","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1046\/j.1365-2133.2002.500210.x","article-title":"Is topical tacrolimus effective in alopecia areata universalis?","volume":"147","author":"Feldmann","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1087-0024.2003.00811.x_bb0050","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/1381612013398266","article-title":"Current and potential agents for the treatment of alopecia areata","volume":"7","author":"Freyschmidt-Paul","year":"2001","journal-title":"Curr Pharm Des"},{"key":"10.1046\/j.1087-0024.2003.00811.x_bb0055","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nm804","article-title":"Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease","volume":"9","author":"Ghoreschi","year":"2003","journal-title":"Nat Med"},{"key":"10.1046\/j.1087-0024.2003.00811.x_bb0060","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1001\/archderm.138.7.916","article-title":"Mediation of alopecia areata by cooperation between CD4+and CD8+T lymphocytes: Transfer to human scalp explants on Prkdc (scid) mice","volume":"138","author":"Gilhar","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1046\/j.1087-0024.2003.00811.x_bb0065","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1046\/j.0022-202x.2001.01583.x","article-title":"Melanocyte-associated T cell epitopes can function as autoantigens for transfer of alopecia areata to human scalp explants on Prkdc (scid) mice","volume":"117","author":"Gilhar","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1087-0024.2003.00811.x_bb0070","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1172\/JCI551","article-title":"Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice","volume":"101","author":"Gilhar","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1087-0024.2003.00811.x_bb0075","first-page":"261","article-title":"Etanercept for psoriasis and psoriatic arthritis","author":"Gottlieb","year":"2003"},{"key":"10.1046\/j.1087-0024.2003.00811.x_bb0080","series-title":"Therapy of Moderate-to-Severe Psoriasis 2nd edn","first-page":"307","article-title":"Infliximab for psoriasis","author":"Gottlieb","year":"2003"},{"key":"10.1046\/j.1087-0024.2003.00811.x_bb0085","doi-asserted-by":"crossref","unstructured":"Gottlieb AB, Miller B, Lowe N, et al: Subcutaneously administered efalizumab (anti-CD11a) improves signs and symptoms of severe plaque psoriasis. J CutanMed Surg, in Press","DOI":"10.1007\/s10227-002-0118-1"},{"key":"10.1046\/j.1087-0024.2003.00811.x_bb0090","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0190-9622(90)70032-D","article-title":"Oral cyclosporine for the treatment of alopecia areata","volume":"22","author":"Gupta","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.1087-0024.2003.00811.x_bb0095","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/sj.jidsp.5640218","article-title":"The potential role of cytokines and T cells in alopecia areata","volume":"4","author":"Hoffmann","year":"1999","journal-title":"J Invest Dermatol Symp Proc The"},{"key":"10.1046\/j.1087-0024.2003.00811.x_bb0100","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/1523-1747.ep12395722","article-title":"Cytokine mRNA levels in alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone","volume":"103","author":"Hoffmann","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1087-0024.2003.00811.x_bb0105","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/1523-1747.ep12611409","article-title":"Topical minoxidil in alopecia areata. No effect on the perifollicular lymphoid infiltration","volume":"99","author":"Khoury","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1087-0024.2003.00811.x_bb0110","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1001\/archderm.138.10.1341","article-title":"Clinical and immunologic assessment of patients with psoriasis in a randomized, double-blind, placebo-controlled trial using recombinant human interleukin 10","volume":"138","author":"Kimball","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1046\/j.1087-0024.2003.00811.x_bb0115","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1046\/j.1365-2133.2002.04760.x","article-title":"Novel immune-based therapies for psoriasis","volume":"146","author":"Kirby","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1087-0024.2003.00811.x_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1067\/mjd.2002.120568","article-title":"The immunologic basis for the treatment of psoriasis with new biologic agents","volume":"46","author":"Krueger","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.1087-0024.2003.00811.x_bb0125","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1067\/mjd.2002.127247","article-title":"A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis","volume":"47","author":"Krueger","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.1087-0024.2003.00811.x_bb0130","first-page":"74","article-title":"Tacrolimus (FK506): Experience in dermatology","volume":"5","author":"Lawrence","year":"1998","journal-title":"Dermatologic Ther"},{"key":"10.1046\/j.1087-0024.2003.00811.x_bb0135","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2133.1996.tb01149.x","article-title":"In vivo depletion of CD8+T Cells restores hair growth in the DEBR model for alopecia areata","volume":"135","author":"McElwee","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1087-0024.2003.00811.x_bb0140","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1046\/j.1365-2133.1999.02705.x","article-title":"Partial restoration of hair growth in the DEBR model for alopecia areata after in vivo depletion of CD4+T cells","volume":"140","author":"McElwee","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1087-0024.2003.00811.x_bb0145","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(00)02530-7","article-title":"Etanercept in the treatment of psoriatic arthritis and psoriasis: A randomised trial","volume":"356","author":"Mease","year":"2000","journal-title":"Lancet"},{"key":"10.1046\/j.1087-0024.2003.00811.x_bb0150","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1365-2133.1997.tb03788.x","article-title":"A novel anti-inflammatory drug, SDZ ASM 981, for the topical and oral treatment of skin diseases: in vivo pharmacology","volume":"137","author":"Meingassner","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1087-0024.2003.00811.x_bb0155","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1067\/mjd.2001.117850","article-title":"The treatment of moderate to severe psoriasis with a new anti-CD11a monoclonal antibody","volume":"45","author":"Papp","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.1087-0024.2003.00811.x_bb0160","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1056\/NEJM199909233411307","article-title":"Treatment of hair loss","volume":"341","author":"Price","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1087-0024.2003.00811.x_bb0165","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0733-8635(05)70394-6","article-title":"Heritable factors distinguish two types of alopecia areata","volume":"14","author":"Price","year":"1996","journal-title":"Dermatol Clin"},{"key":"10.1046\/j.1087-0024.2003.00811.x_bb0170","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/81359","article-title":"Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation","volume":"6","author":"Rothbard","year":"2000","journal-title":"Nat Med"},{"key":"10.1046\/j.1087-0024.2003.00811.x_bb0175","doi-asserted-by":"crossref","first-page":"628","DOI":"10.4065\/70.7.628","article-title":"Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through, 1989","volume":"70","author":"Safavi","year":"1995","journal-title":"Mayo Clin Proc The"},{"key":"10.1046\/j.1087-0024.2003.00811.x_bb0180","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0889-8561(03)00074-2","article-title":"New treatment for atopic dermatitis","volume":"22","author":"Schneider","year":"2002","journal-title":"Immunol Allergy Clinics North America"},{"key":"10.1046\/j.1087-0024.2003.00811.x_bb0185","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/archderm.138.5.657","article-title":"Biologic therapy for psoriasis: the new therapeutic frontier","volume":"138","author":"Singri","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1046\/j.1087-0024.2003.00811.x_bb0190","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1001\/archderm.136.1.124","article-title":"Topical tacrolimus: Treatment failure in a patient with alopecia areata","volume":"136","author":"Thiers","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1046\/j.1087-0024.2003.00811.x_bb0195","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0190-9622(84)70152-6","article-title":"T cell subpopulations in alopecia areata","volume":"11","author":"Todes-Taylor","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.1087-0024.2003.00811.x_bb0200","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/1523-1747.ep12412584","article-title":"Human leukocyte antigen\u2014DQB1*03 alleles are associated with alopecia areata","volume":"103","author":"Welsh","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1087-0024.2003.00811.x_bb0205","first-page":"1063","article-title":"Predictive model for immunotherapy of alopecia areata with diphencyprone","volume":"137","author":"Wiseman","year":"2001","journal-title":"Arch Dermatol"}],"container-title":["Journal of Investigative Dermatology Symposium Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15529680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15529680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,24]],"date-time":"2019-02-24T00:57:00Z","timestamp":1550969820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15529680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,10]]}},"alternative-id":["S0022202X15529680"],"URL":"https:\/\/doi.org\/10.1046\/j.1087-0024.2003.00811.x","relation":{},"ISSN":["1087-0024"],"issn-type":[{"value":"1087-0024","type":"print"}],"subject":[],"published":{"date-parts":[[2003,10]]}}}